SCHEMBL926528

SCHEMBL926528

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3CCC2C(=O)NCCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.55
PSEN2 P49810 1/20 0.55
APH1B Q8WW43 1/20 0.55
NCSTN Q92542 1/20 0.55
APH1A Q96BI3 1/20 0.55
PSENEN Q9NZ42 1/20 0.55
FKBP1A P62942 6/20 0.50
POLB P06746 2/20 0.49
RORC P51449 1/20 0.49
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
GAA P10253 2/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MAPK1 P28482 2/20 0.46
ALDH1A1 P00352 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ESR1 P03372 1/20 0.44
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926338 0.91 FKBP1A (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL927527 0.88 FKBP1A (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926406 0.85 FKBP1A (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926489 0.85 FKBP1A (0.52) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926912 0.84 FKBP1A (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL927595 0.84 POLB (0.51) FKBP1APOLBMEN1KMT2AMAPK1
SCHEMBL926686 0.84 ESRRG (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926922 0.84 FKBP1A (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926834 0.84 RORC (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL929397 0.84 ESRRG (0.47) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed
EP-1742918-A1 LXR RECEPTOR MODULATORS LABORATOIRES FOURNIER S.A. (FR) 2007-01-17 EP disclosed
WO-2005121093-A1 LXR RECEPTOR MODULATORS LABORATOIRES FOURNIER S.A. (FR) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD PSEN1 281/4885PSEN2 258/4885APH1B 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.